FABP1 and cervical squamous intraepithelial neoplasia: The third, Igarashi et al. [23], using an identical conditioning regime to that used by Er et al. and, utilising a novel bio-marker, urinary liver-type fatty acid-binding protein (L-FABP) as a primary endpoint, demonstrated a significant reduction of CIN from 26.9 to 7.7 % in the remote ischaemic preconditioned group.